CFDE Data Portal | Search LINC01974

	Label	Description
	LINC01974 Gene (Entity type)	ENSG00000261886 - long intergenic non-protein coding RNA 1974
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228017 parthenolide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE134029 cisplatin 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146687 irinotecan 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 5 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01974

ENSG00000261886 - long intergenic non-protein coding RNA 1974

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

GSE228017 parthenolide 0 v 1 human up

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE134029 cisplatin 3 v 1 human up

A Gene Set from LINCS

GSE146687 irinotecan 2 v 3 human dn

A Gene Set from LINCS

GSE148200 gemcitabine 1 v 5 human up

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 2 v 4 human dn

A Gene Set from LINCS

GSE233679 nicotinamide 5 v 10 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 0 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.